Compare Niramas Utama Tbk. (JELI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Niramas Utama Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Niramas Utama Tbk. trades at Rp635 (market cap 848.22B, 10.75M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Niramas Utama Tbk. is the larger of the two by market cap, and Niramas Utama Tbk. is more actively traded (10.75M versus 843K). Which is the better fit depends on your goals.
| JELI | LABS | |
|---|---|---|
Market Cap | 848.22B | 635.95B |
Volume | 10.75M | 843K |
Lot | 107.48K | 8.43K |
Turnover | 6.9B | 137.6M |
Average Price | 642.24 | 163.22 |
Value | 6.9B | 137.6M |
Indicative Equilibrium Price | 635 | 165 |
Indicative Equilibrium Volume | 6.4K | 246 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Niramas Utama Tbk.
PT. Niramas Utama Tbk. (the Company) formerly PT Nata Sari Raya was established based on Notarial Deed No. 86 dated 22 November 1990, by Notary Samsul Hadi, S.H. The Company started its commercial operations in 1994. The parent entity and the ultimate parent entity of the Company are PT Niramas Utama International and PT Supra Sentral Investama
Read more on JELI →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
